New compounds can activate prodrugs at predetermined locations in the body

Researchers from IOCB Prague have succeeded in preparing compounds capable of activating prodrugs at predetermined locations in the body, enhancing their effectiveness and expediting their action. This will make it possible, for example, to more precisely target malignant tumors, which might greatly advance the potential of anti-cancer therapies.